The development of NSCLC involves multiple signaling pathways [5], such as the MAPK [6], PI3K/AKT/mTOR [7], Wnt [8], cell cycle [9], and DNA damage pathways [10]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.